Medical News Podcast cover art

All Episodes

Medical News Podcast — 381 episodes

#
Title
1

Hearing aids help slow brain aging process in adults with mild cognitive impairment

2

Retinal Disease Updates from AAO 2025

3

Could switching direct oral anticoagulants after breakthrough stroke be unnecessary?

4

Highlights From ISC 2026: The CREST-2 Cognitive Substudy and Oral Health and Stroke Risk

5

AI, Machine Learning, and HRCT in ILD: Fibrosis Quantification

6

HER2 in Genitourinary Cancers: Clinical Relevance and Real-World Testing Considerations

7

Could first-line ablation soon replace antiarrhythmic drugs for persistent atrial fibrillation?

8

CLL and ASH 2025: CAR T-cell Therapy and Data on Vaccination and Cancer Screening

9

Could survival in metastatic pancreatic cancer finally be improving?

10

Obstructive Hypertrophic Cardiomyopathy: The Role of Septal Reduction Therapy in the Current Era of Cardiac Myosin Inhibitors

11

Can shingles vaccine drastically cut risk of serious cardiac events?

12

Key Themes From the 49th Annual Macula Society Meeting

13

CGRP and Women’s Health: Migraine Across the Hormonal Lifespan

14

Can stable post-MI patients safely stop beta-blockers after 1 year?

15

AI, Machine Learning, and HRCT in ILD: Standardizing Diagnostics

16

Could giving whole blood in the field improve survival in patients with traumatic hemorrhage?

17

Highlights From ISC 2026: Insights Into Secondary Stroke Prevention From the OCEAN-STROKE Trial

18

CLL at ASH 2025: CLL17

19

Neuromodulation in Migraine Care: Insights From the 2025 IHS Guidelines

20

Diagnosing Obstructive Hypertrophic Cardiomyopathy: Key Considerations for Clinicians

21

ACR 2025: Risk of Proteinuria in Patients With Lupus Nephritis and the Timing of Kidney Biopsy in Patients With SLE

22

Could anticoagulant choice cut bleeding risk in half for patients with acute VTE?

23

2025 San Antonio Breast Cancer Symposium: Evolving First-Line Approaches in Metastatic HER2+ Breast Cancer

24

Could personalized breast screening replace annual mammograms?

25

HER2+ Strategies in GI Cancers: ESMO 2025 Insights

26

Could a new anti-CD20 therapy transform the treatment for systemic lupus?

27

2025 San Antonio Breast Cancer Symposium: Maintenance Therapy Updates in Metastatic HER2+ Breast Cancer

28

ACR 2025: Mortality Risk With Belimumab and GLP-1 Agonists in Lupus and Lupus Nephritis

29

New Data on Risk Factors and Treatment Regimens for Patients With Neovascular AMD and DME

30

Can oral semaglutide reduce heart failure events in patients with heart failure with preserved ejection fraction?

31

2025 San Antonio Breast Cancer Symposium: Key Updates in Early-Stage HER2+ Breast Cancer

32

CLL at ASH 2025: BRUIN Studies and a Triplet for Richter Transformation

33

Could new pulmonary embolism guidelines safely reduce hospitalizations for some patients?

34

Evolving HER2+ Testing and Targeted Therapies in GI Cancers: Latest Insights From ESMO 2025

35

OnabotulinumtoxinA and Migraine: Clinical Insights and Recent Evidence

36

Can achieving prediabetes remission cut CV death and heart failure risk?

37

HER2+ Endometrial and Ovarian Cancers: Targeted Therapy Highlights From ESMO 2025

38

HER2+ Endometrial and Ovarian Cancers

39

Can an oral PCSK9 inhibitor finally close the LDL gap for high-risk patients?

40

Are UTIs being over treated via telehealth—and who actually needs antibiotics?

41

Sequencing Targeted Therapies in the Management of Patients With CLL

42

What does current evidence show about acetaminophen use in pregnancy?

43

Should clinicians routinely ask patients about firearm access?

44

Are missed 2-month vaccines the strongest warning sign for future MMR refusal?

45

Do GLP-1 weight-loss drugs also reduce asthma attacks in teens?

46

What happens to factor Xa reversal strategies now that andexanet is leaving the U.S.?

47

HER2+ Lung Cancer at ESMO 2025

48

HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations

49

HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained

50

Does tirzepatide offer comparable cardiovascular safety to GLP-1 therapy in diabetes?

51

Veterans and Interstitial Lung Disease: Risk Prediction Models and Early Detection

52

Veterans and Interstitial Lung Disease: Providing Specialized Care in Rural and Underserved Areas

53

Highlights From CHEST 2025: Proactive Intervention and Precision Medicine

54

Should remission—not delay—be the new goal for prediabetes?

55

Highlights From CHEST 2025: Earlier Detection and Targeted Interventions

56

Managing CNS Disease in HER2+ Breast Cancer

57

The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 2)

58

What are the potential health and safety implications for children now that a CDC advisory panel has moved to withdraw the universal birth-dose recommendation for the hepatitis B vaccine in newborns?

59

The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 1)

60

Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 2)

61

Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 1)

62

Could a routine antibiotic quietly trigger severe respiratory failure in young patients?

63

Emerging Therapeutics and Biosimilars: Advancing the Future of Osteoporosis Care

64

Sequential Therapy and Switching Strategies in Osteoporosis: Insights for Improved Outcomes

65

How much can staying active in adulthood realy cut dementia risk?

66

Advanced Imaging in Osteoporosis: Integrating Trabecular Bone Score for Enhanced Fracture Risk Assessment

67

How are major medical societies responding to FDA changes to menopause therapy labels?

68

Could over-the-counter painkillers truly outperform opioids after dental surgery?

69

Managing CNS Involvement in HER2+ Lung Cancer

70

Could a chemo-free regimen surpass the standard triplet in HER2+ Breast Cancer?

71

Evolving Second-Line Strategies in HER2+ Lung Cancer

72

First-Line Strategies in HER2+ Lung Cancer

73

Can HER2+ Metastatic Breast Cancer Be Cured?

74

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

75

Could there be a long-awaited breakthrough in first-line therapy for triple-negative breast cancer?

76

Early-Stage HER2+ Breast Cancer

77

Could the choice of diabetes medication change a patient’s cardiovascular risk?

78

Do updated COVID vaccines protect U.S. veterans from severe outcomes?

79

When can stage II–III colon cancer be considered cured after treatment?

80

ICML 2025: Novel Agents in CLL

81

Could SGLT2 inhibitors help lower the risk of sudden cardiac death?

82

ICML 2025: Regimens for Patients With High-Risk CLL

83

ICML 2025: Fixed-Duration and MRD-Guided Regimens in CLL

84

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

85

Should children under 4 still get the MMRV vaccine? The American Academy of Pediatrics says yes

86

Breaking the Migraine Cycle: Understanding Medication Overuse Headache

87

Future Directions in Small Cell Lung Cancer Treatment

88

Small Cell Lung Cancer: Second-line Options Following Maintenance

89

Perspectives on Maintenance Therapy in Small Cell Lung Cancer

90

Should clopidogrel replace aspirin as the standard for CAD prevention?

91

Treat to Target: What it Is and How to Implement

92

Earlier Use of Biologics for Treating Lupus

93

Is FDA-backed elastography poised to replace biopsy as the driver of MASH drug development?

94

2025 Guideline Summary for the Clinical Treatment and Management of Systemic Lupus Erythematosus

95

Emerging Therapies in SLE: Recent Studies and Potential Game-Changing Treatments

96

Non-Invasive Biomarkers in SLE: A Promise of Better Diagnosis, Management, and Personalized Treatment?

97

New Guidelines for the Screening, Treatment, and Management of Lupus Nephritis

98

What does FDA’s approval of generic liraglutide mean for obesity care?

99

How will the first approval for MASH with fibrosis alter treatment pathways?

100

How are telehealth abortion prescriptions reaching ban states?

101

Can a smartphone app reduce suicide attempts after psychiatric hospitalization?

102

Can blood tests reliably guide Alzheimer’s diagnosis in patients with cognitive decline?

103

How do sulfonylureas compare to DPP-4 inhibitors for cardiovascular safety in T2D?

104

Could methotrexate replace prednisone as first-line therapy in lung sarcoidosis?

105

Geographic Atrophy: Where Do We Stand and Where are We Going?

106

Advances in Retinal Therapy: Emerging Strategies for DME and wAMD

107

Richard Ostfeld on Tick-Borne Threats in Changing Ecosystems

108

AI and Telehealth in Diabetic Retinopathy: From Screening to Specialist Care

109

GLP-1s and the Retinal Patient: What Every Eye Care Professional Should Know

110

Floaters: Imaging Tools, Decision-Making, Including Surgery and Patient Counseling

111

Geographic Atrophy: Navigating the Latest Advances in Care

112

“What does full FDA approval of Moderna’s COVID vaccine mean for high-risk kids under 12?”

113

Maintenance Therapy Strategies in Small Cell Lung Cancer

114

ASCO 2025: Emerging Therapies in Small Cell Lung Cancer

115

ASCO 2025: Updates in Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

116

How many avoidable deaths could occur by 2030 if abrupt funding cuts to USAID are not reversed?

117

What’s the latest on the national outbreak of Measles in the US?

118

ASCO 2025 Insights Into HER2+ Breast Cancer: DESTINY-Breast06, SHR-A1811, Rechallenge With T-DXd Post Grade 1 ILD, and More

119

ASCO 2025 Insights Into HER2+ Breast Cancer: DESTINY-Breast09, PATINA, MINI Trial, and More

120

Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

121

Highlights From ATS 2025: Approach to the Evaluation and Management of Interstitial Lung Abnormalities—The Official ATS Clinical Statement

122

Could a twice yearly injectable pre-exposure prophylaxis drug help curb the 44-year old HIV epidemic?

123

Emerging and Future Biomarkers for Interstitial Lung Disease

124

Advances and Future Treatment Targets for Interstitial Lung Disease

125

Can an oral diabetes drug reduce hepatic scarring from MASH?

126

The Role of MRD Testing in CLL

127

Toxicity and Treatment Management in CLL

128

CLL Debate: BTKi and BCL2i Combinations in Frontline Treatment of CLL

129

Breaking Barriers in CLL: Immunotherapy with CAR-T and Bispecific Antibodies

130

Can increased physical activity after adjuvant therapy for colon cancer improve disease-free survival?

131

Evolving CLL Therapy: The Power of Doublet and Triplet Regimens

132

Safety of Treatments for HER2-Mutant Lung Cancer

133

Advances in Treating HER2-Mutant Lung Cancer: Efficacy

134

What's fueling the rapid rise of measles in North America despite vaccine availability?

135

Could a new rescue inhaler strategy reduce severe asthma attacks in mild cases?

136

Could ending PEPFAR lead to 1 million new pediatric HIV cases by 2030?

137

Revisiting Anemia Response in Myelofibrosis: Revised International Working Group Criteria

138

Leukemic Transformation in Myelofibrosis: Risks, Realities, and Evolving Strategies

139

Understanding Secondary Myelofibrosis: Diagnosis, Treatment, and Prognosis

140

How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations?

141

Migraine Missteps: Common Diagnostic Pitfalls and How to Avoid Them

142

Game Changer: Are CGRP Inhibitors the New First Line for Migraine Prevention?

143

Could a new HER2-targeted therapy change outcomes in previously treated NSCLC?

144

Lifestyle and Cognitive Health: A discussion with Drs. Elizabeth Kensinger and Andrew Budson

145

Could measles become endemic in the U.S. again within 25 years?

146

What does Mexico’s first fatal H5N1 avian flu case tell us about current risks to humans?

147

Could genetic testing improve prostate cancer screening beyond PSA?

148

Mary Beth Cicero on Reimagining the IUD: A Painless Future for Contraception

149

HER2+ Lung Cancer Treatment: Past, Present, and Future

150

Can statins reduce liver cancer risk in patients with chronic liver disease?

151

HER2 Alterations in Lung Cancer

152

HER2 Biomarker Testing in Lung Cancer

153

Migraine: Updates from the 2024 European Headache Congress

154

Could a new combination improve first-line therapy for myelofibrosis?

155

Migraine Debates: Initial Preventive Therapy and Status Migraine

156

Pharmacological Management of Postpartum Depression: Pros and Cons

157

Barriers to Care Engagement for Postpartum Depression

158

Suicide Risk in Postpartum Depression: Screening and Management

159

Could GLP-1 receptor agonists reduce the risk of blood cancers in type 2 diabetes patients?

160

Can AI reduce false positives and biopsies in breast ultrasound exams?

161

Osteoporosis: Common Questions and Clinical Conundrums

162

Operationalization of a Bisphosphonate “Drug Holiday”

163

Preservation of Perimenopausal Bone Health

164

What are the details around the first measles death in the US in 10 years?

165

Dr. Andrew Budson on consciousness and the role they play on memory

166

How severe is this flu season compared to recent years?

167

Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities

168

Navigating HER2+ Early Breast Cancer: Diagnosis, Treatment Planning, and De-Escalation

169

Why are measles outbreaks surging in Texas and New Mexico?

170

Specialist Spotlight: Parental favoritism and its impact on family dynamics and mental health

171

Specialist Spotlight: Marlie Tondac investigating learning and attention in young children.

172

Can a urine test reduce unnecessary prostate biopsies?

173

Could immunotherapy redefine treatment for Estrogen Receptor positive/HER2 negative breast cancer?

174

Approaching Tough Discussions in ILDs: Lung Transplantation and End-of-Life Issues

175

Insights Into Managing Comorbidities, Discussing Quality of Life, and Benefits of Pulmonary Rehab in Patients With ILDs

176

Could a fully human monoclonal antibody reduce bleeding risk in atrial fibrillation patients?

177

Principles of Selecting Pharmacotherapy for ILDs

178

Diagnosing and Classifying ILDs

179

What is the impact of red meat intake and the risk of dementia and cognitive decline?

180

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 3

181

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 2

182

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 1

183

The Basics of HER2+ in Lung Cancers

184

2024 San Antonio Breast Cancer Symposium Insights on HER2+ Early Breast Cancer: MARGOT Trial, Risk-Reducing Surgeries/Survival, and More

185

What happens to patient care when private equity takes over hospitals?

186

2024 San Antonio Breast Cancer Symposium Insights on HER2+ Early Breast Cancer: TOUCH and DTP Trials and More

187

Clinical Trials in Myelofibrosis: Endpoints

188

Cytopenic Myelofibrosis

189

How many minutes of life does smoking 1 cigarette cost?

190

American Society of Hematology Annual Meeting 2024 – Updates in Myelofibrosis (Part 2)

191

American Society of Hematology Annual Meeting 2024 – Updates in Myelofibrosis (Part 1)

192

American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 2)

193

American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 1)

194

What factors are associated with loss to follow-up rates in patients with diabetic retinopathy or diabetic macular edema?

195

Could fewer allergies be linked the gut microbiota of children raised on farms or with pets?

196

Which population is most affected by the rising prevalence of anaphylaxis?

197

Could diet be fueling psoriasis flare-ups?

198

The Impact of Lifestyle and Stress on Memory and Cognition

199

Managing the Signs and Symptoms of Myelofibrosis

200

Clinical Trials in Myelofibrosis: Referral, Recruitment, and Assessment

201

What vaccine preventable disease is surging globally?

202

Postpartum Depression: Importance of Early and Effective Treatment

203

Screening and Diagnosis of Postpartum Depression

204

What is the risk of rhabdomyolysis in patients taking both SGLT2 inhibitors and statins?

205

Postpartum Depression: The Treatment Landscape

206

Shifting the Paradigm: Biologics in the Management of Food Allergy

207

Case-Based Approach to a Patient With Food Allergy

208

A Personalized Approach to Treating Patients With ANCA‑Associated Vasculitis

209

Can starting a medication abortion before confirming an intrauterine pregnancy offer a safe, effective alternative to waiting?

210

Induction Therapy in Patients With ANCA-Associated Vasculitis Part 2: Glucocorticoids and Plasma Exchange

211

Induction Therapy in Patients With ANCA-Associated Vasculitis Part 1: Induction Chemotherapy

212

The Future of Treating HER2+ Lung Cancer (Part 2)

213

Maintenance Therapy in ANCA-Associated Vasculitis

214

Steroid Reduction and Steroid Sparing Approaches to the Management of ANCA-Associated Vasculitis

215

The Future of Treating HER2+ Lung Cancer (Part 1)

216

ANCA-Associated Vasculitis: Renal Manifestations and Guideline Updates

217

Exploring HER2-Low and Ultralow in GI Cancers, Newer Therapies Targeting HER2, and Current Testing Methods

218

Goal-Directed Approach to Long-Term Management of Fracture Risk in Patients With Osteoporosis (Part 2)

219

Goal-Directed Approach to Long-Term Management of Fracture Risk in Patients With Osteoporosis (Part 1)

220

Navigating Toxicities in Gastroesophageal Cancer Treatment and Exploring HER2+ in Biliary Tract Cancers

221

Optimal Use of Denosumab in Patients With Postmenopausal Osteoporosis

222

Using Anabolic Agents in Patients With Postmenopausal Osteoporosis

223

The Role and Function of HER2+ in GI Cancers: Focus on Gastroesophageal and Colorectal Cancers

224

How does poor sleep in midlife impact brain health years later?

225

HER2+ in Gynecologic Cancers (Part 2)

226

HER2+ in Gynecologic Cancers (Part 1)

227

HER2+ Pan-Tumor Basics (Part 2)

228

HER2+ Pan-Tumor Basics (Part 1)

229

Which biologic treatment was the first to receive FDA approval for patients with uncontrolled COPD?

230

Specialist Spotlight: Daniel Daneshvar, MD, PhD on Traumatic Brain Injuries

231

Is hearing loss associated with increased risk of cognitive impairment?

232

What impact does defib pad position have on outcomes for cardiac arrest?

233

Advances in Migraine Treatment (Part 3)

234

Advances in Migraine Treatment (Part 2)

235

Advances in Migraine Treatment (Part 1)

236

Shifting the Focus: Proactive Prevention in Migraine Management

237

What's the first flu vaccine you can take at home?

238

Sinus Headache or Migraine? Unraveling the Truth

239

Treating Through Uncertainty: Selecting Migraine Treatment in Patients Considering Pregnancy

240

Approaches to Migraine Counseling and Treatment in Breastfeeding Patients

241

What is the latest on Cloud-Based AI Endoscopy?

242

What is the latest on the mpox outbreak in Africa and beyond?

243

What is the appropriate duration for beta-blockers after a myocardial infarction?

244

Long COVID affects adolescents differently than younger children

245

Specialist Spotlight: Dr. David Wohl on the current landscape in HIV treatment

246

Brain-computer interface enables man with ALS to speak again

247

Interstitial Lung Abnormalities as a Key Precursor to Interstitial Lung Disease (Part 2)

248

Interstitial Lung Abnormalities as a Key Precursor to Interstitial Lung Disease (Part 1)

249

Specialist Spotlight: Interstitial Lung Diseases for the Non‑Pulmonologist (Part 2)

250

Specialist Spotlight: Interstitial Lung Diseases for the Non‑Pulmonologist (Part 1)

251

FDA approves first nasal spray for treatment of anaphylaxis

252

The Role of Advanced Practice Providers in Diagnosing and Treating Interstitial Lung Diseases (Part 2)

253

The Role of Advanced Practice Providers in Diagnosing and Treating Interstitial Lung Diseases (Part 1)

254

Understanding HER2‑Low Breast Cancer: Challenges of Evolving Definition, Testing Approaches, and Treatment Decision‑Making

255

HER2 Testing in Breast Cancer: Clinical Relevance, Need, Testing Methods, Guidelines, and Interpretation of Results (Part 2)

256

Fourteen modifiable risk factors can help prevent dementia

257

HER2 Testing in Breast Cancer: Clinical Relevance, Need, Testing Methods, Guidelines, and Interpretation of Results (Part 1)

258

Twice-yearly lenacapavir provides 100% protection against HIV

259

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 3)

260

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 2)

261

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 1)

262

Study identifies racial disparities in opioid prescribing

263

Specialist Spotlight:Surgical Care of Patients With Osteoporosis

264

Specialist Spotlight: Perioperative Care of Patients With Osteoporotic Fractures

265

Specialist Spotlight: The Role of Nurse Practitioners and Physician Assistants in the Management of Patients With Postmenopausal Osteoporosis

266

Emerging Potential Treatment Options for Schizophrenia With Negative and Cognitive Symptoms (Part 2)

267

Investigational drug boosts pregnancy rates in women undergoing IVF, ICSI

268

Emerging Potential Treatment Options for Schizophrenia With Negative and Cognitive Symptoms (Part 1)

269

Specialist Spotlight: The Role of Assessment and Screening for Cognitive Impairment in Patients With Schizophrenia (Part 2)

270

Specialist Spotlight: The Role of Assessment and Screening for Cognitive Impairment in Patients With Schizophrenia (Part 1)

271

Specialist Spotlight: Recognizing the Three Symptoms Domains of Schizophrenia in the Outpatient Clinical Practice (Part 2)

272

FDA approves new drug for early Alzheimer's disease

273

Recognizing the Three Symptoms Domains of Schizophrenia in the Outpatient Clinical Practice (Part 1)

274

Islet cell transplantation may help some patients with type 1 diabetes achieve insulin independence

275

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 3)

276

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 2)

277

Weight maintenance possible following semaglutide, liraglutide discontinuation

278

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 1)

279

Lorlatinib shows unprecedented success in advanced NSCLC

280

Tattoo exposure associated with increased risk for malignant lymphoma

281

Novel technique shows promise for significant weight loss

282

Specialist Spotlight: Biosimilars in Retinal Medicine (Part 2)

283

Recovery possible for some patients with TBI removed from life support

284

Specialist Spotlight: Biosimilars in Retinal Medicine (Part 1)

285

Specialist Spotlight: Urothelial Carcinoma Update From the ASCO GU Symposium 2024

286

ASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADOR

287

Specialist Spotlight: Advanced Urothelial Carcinoma: Considerations in Therapeutic Sequencing

288

Changes in antibody levels predict which children will outgrow peanut allergies

289

Specialist Spotlight: Neoadjuvant Approach to Urothelial Carcinoma: Treatment With Curative Intent

290

Specialist Spotlight: Updates on the Diagnosis of High‑Risk Postmenopausal Osteoporosis (Part 2)

291

Specialist Spotlight: Updates on the Diagnosis of High‑Risk Postmenopausal Osteoporosis (Part 1)

292

USPSTF lowers recommended age for breast cancer screening

293

Secular differences in early life environment affect brain volume, dementia risk

294

Acetaminophen use during pregnancy not associated with neurodevelopmental disorders

295

Physician empathy impacts outcomes in patients with chronic pain

296

Remote monitoring can identify early signs of Alzheimer’s disease

297

More exposure to outdoor light at night linked to higher stroke risk

298

Specialist Spotlight: Alicia Morgans, MD, MPH on the Care of Cancer Survivors

299

No evidence of MRI-detectable brain injury in people with Havana Syndrome

300

Specialist Spotlight: Naushira Pandya, MD, CMD, FACP and Hady Masri, DO on the Unique Risks of the Geriatric Population and RSV: Part 2

301

Psychoactive cannabis use common among high school seniors

302

Specialist Spotlight: Raagini Jawa, MD, MPH, FASAM on Harm Reduction for Individuals with Substance Use Disorders

303

Specialist Spotlight: Jonathan E. Rosenberg, MD and Alicia K. Morgans, MD, MPH on Late‑Breaking Presentations on EV‑302 and AMBASSADOR at ASCO Genitourinary Symposium 2024

304

Specialist Spotlight: Naushira Pandya, MD, CMD, FACP and Hady Masri, DO on the Unique Risks of the Geriatric Population and RSV: Part 1

305

Generics for fingolimod associated with side effects, MS relapse

306

Specialist Spotlight: Alison Buttenheim, PhD on Vaccine Acceptance and Infectious Disease Prevention

307

Previously Untreated Advanced Urothelial Carcinoma: Update From ESMO 2023

308

Study Discussion: Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

309

Annual breast cancer screening at 40 saves lives

310

Abortion meds can be safely delivered through telemedicine

311

Three Symptom Domains of Schizophrenia: Positive, Negative, and Cognitive Impairment – Part 2

312

Long COVID increases risk for mental health disorders

313

Specialist Spotlight: Sanjai Rao, MD and Dawn Velligan, PhD on Symptom Domains of Schizophrenia in the Outpatient Setting (Part 1)

314

Alzheimer’s disease may be transmissable in rare cases

315

Specialist Spotlight: Raajit K. Rampal, MD, PhD and Ghaith Abu‑Zeinah, MD on Managing Splenomegaly in Myelofibrosis

316

COVID-19 pandemic had a profound impact on diabetes outcomes

317

Specialist Spotlight: Raajit K. Rampal, MD, PhD and Ghaith Abu‑Zeinah, MD on Sequencing JAK inhibitors in Myelofibrosis

318

HPV vaccine highly effective when administered early

319

Oral nirmatrelvir fails to reduce risk of long COVID

320

Modifiable risk factors for young-onset dementia identified

321

Specialist Spotlight: Dr. Krystal Kittle on Aging and Minority Communities

322

Blood test identifies patients at high risk for suicide

323

Specialist Spotlight: Ashton Applewhite on Ageism in Healthcare

324

Specialist Spotlight: Michaela Khan on Running Physiology

325

Specialist Spotlight: Dr. Cara Ocobock on Female Endurance

326

Discontinuation of tirzepatide leads to weight regain

327

Early treatment may induce remission in children born with HIV

328

Brain Care Score predicts dementia, stroke risk

329

Semaglutide reduces cardiovascular event risk in people without diabetes

330

Cat-borne parasite contributes to frailty in older adults

331

Experts create core outcomes set for long COVID

332

American Cancer Society updates lung cancer screening guidelines

333

Adult ADHD associated with increased risk for dementia

334

Long COVID is associated with reduced serotonin levels

335

Specialist Spotlight: Highlights From the 2023 Annual Meeting of American Society of Retina Specialists: Part 2

336

Specialist Spotlight: Highlights From the 2023 Annual Meeting of American Society of Retina Specialists: Part 1

337

Specialist Spotlight: What regimen for retinal disease? Drs. Schneider and Do on the PULSAR study 1-year data

338

Wastewater surveillance provides lead time for pediatric RSV season

339

Specialist Spotlight: How long between injections for retinal disease? Drs. Schneider and Do on the PHOTON study 2-year data

340

Specialist Spotlight: Dr. Tuan Vu on ALS and What's New in Neurology

341

Which therapies have the strongest evidence for smoking cessation?

342

Semaglutide shows promise in obesity-related heart failure

343

Specialist Spotlight: Dr. Chloe Zera Reflects One Year After the End of Roe v. Wade

344

Work stress increases risk for heart disease in men

345

Most older adults not aware of the new RSV vaccine

346

Specialist Spotlight: Does switching cost more? A cost analysis based on DRCR Network Protocol AC when treating patients

347

Specialist Spotlight: What to start DME patient on? A discussion of DRCR Network Protocol AC

348

Pharmacological duodenal exclusion therapy shows promise

349

Specialist Spotlight: Dallas Ducar on Providing Gender-Affirming Care (Part 2)

350

First 10 drugs named for Medicare price negotiations

351

Specialist Spotlight: Dallas Ducar on Providing Gender-Affirming Care (Part 1)

352

RSV in Adults Who Require Hospitalization and Their Management

353

Piroxicam boosts efficacy of emergency contraceptive pill

354

RSV Infections in Immunocompromised Adults

355

Playing football may increase risk of developing Parkinson's disease

356

Myelofibrosis: Updates from EHA 2023

357

Semaglutide reduces cardiovascular risk by 20%

358

Myelofibrosis: Updates from ASCO 2023

359

Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 2)

360

Universal flu vaccine elicits strong immune response

361

Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 1)

362

Insights from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology

363

Almost zero risk of HIV transmission with low viral loads

364

Specialist Spotlight on Diversity, Equity, and Inclusion in Retinal Medicine

365

Specialist Spotlight on Myelofibrosis: JAK inhibitor Drug Choice and Dosing Strategy

366

Specialist Spotlight on Myelofibrosis: Approach to Patients With Myelofibrosis and Anemia

367

Antibiotic exposure may affect COVID-19 severity

368

FDA approves first nonprescription oral contraceptive

369

Concomitant meds can hinder antidepressant response

370

Novel obesity drug leads to substantial weight loss

371

USPSTF recommends anxiety screening for all adults aged <65 years

372

Metformin reduces long COVID risk

373

Osimertinib is a game changer in NSCLC

374

Multidrug-resistant keratitis manageable when treated early

375

Oral therapy for sleep apnea could be a game changer

376

Children show good recovery after pediatric inflammatory multisystem syndrome

377

Specialist Spotlight: Clinical psychologist, Dr. Lisa Harris on the psychological impact of eating disorders, obesity, and diet culture

378

Desulfovibrio bacteria associated with Parkinson's disease

379

FDA approves first RSV vaccine for older adults

380

Specialist Spotlight: Dr. Lofton on weight management and the on-label and off-label uses of GLP-1 agonists

381

Brain changes observed in some patients with long COVID